viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Viited 3294
tüüp :
ajaleht
interneti link :
http://ejhp.bmj.com/content/19/1/57.abstract
uurimisrühmad :
Lausanne - University Hospital, Department of Pharmacy
Autor :
Humbert-Delaloye V, Berger M, Voirol P, Pannatier A.
pealkiri :
In vitro compatibility of remifentanil hydrochloride and sufentanil citrate with selected drugs
publikatsioon :
EJHP ; 19: 57-64. 2012
Tõendite tase :
füüsikaline stabiilsus :
Keemiline püsivus :
Muud meetodid :
Kommentaarid :
ingredientide nimekiri
Furosemide
1 mg/ml
+
Remifentanil hydrochloride
120 µg/ml
+
1 mg/ml
+
Sufentanil citrate
0.005 mg/ml
+
Heparin sodium
416.7 UI/ml
+
Remifentanil hydrochloride
120 µg/ml
+
416.7 UI/ml
+
Sufentanil citrate
0.005 mg/ml
+
Midazolam hydrochloride
1 mg/ml
+
Remifentanil hydrochloride
120 µg/ml
+
1 mg/ml
+
Sufentanil citrate
0.005 mg/ml
+
Potassium phosphate
1 mmol/ml
+
Remifentanil hydrochloride
120 µg/ml
+
1 mmol/ml
+
Sufentanil citrate
0.005 mg/ml
+
Propofol
20 mg/ml
+
Remifentanil hydrochloride
120 µg/ml
+
20 mg/ml
+
Sufentanil citrate
0.005 mg/ml
+
Remifentanil hydrochloride
120 µg/ml
+
Furosemide
1 mg/ml
+
120 µg/ml
+
Heparin sodium
416.7 UI/ml
+
120 µg/ml
+
Midazolam hydrochloride
1 mg/ml
+
120 µg/ml
+
Potassium phosphate
1 mmol/ml
+
120 µg/ml
+
Propofol
20 mg/ml
+
Sufentanil citrate
0.005 mg/ml
+
Furosemide
1 mg/ml
+
0.005 mg/ml
+
Heparin sodium
416.7 UI/ml
+
0.005 mg/ml
+
Midazolam hydrochloride
1 mg/ml
+
0.005 mg/ml
+
Potassium phosphate
1 mmol/ml
+
0.005 mg/ml
+
Propofol
20 mg/ml
+
Mentions Légales
